Literature DB >> 15687196

Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.

Ximena Ortega1, Tracey A Hunt, Slade Loutet, Arlene D Vinion-Dubiel, Anup Datta, Biswa Choudhury, Joanna B Goldberg, Russell Carlson, Miguel A Valvano.   

Abstract

Burkholderia cenocepacia is an opportunistic bacterium that infects patients with cystic fibrosis. B. cenocepacia strains J2315, K56-2, C5424, and BC7 belong to the ET12 epidemic clone, which is transmissible among patients. We have previously shown that transposon mutants with insertions within the O antigen cluster of strain K56-2 are attenuated for survival in a rat model of lung infection. From the genomic DNA sequence of the O antigen-deficient strain J2315, we have identified an O antigen lipopolysaccharide (LPS) biosynthesis gene cluster that has an IS402 interrupting a predicted glycosyltransferase gene. A comparison with the other clonal isolates revealed that only strain K56-2, which produced O antigen and displayed serum resistance, lacked the insertion element inserted within the putative glycosyltransferase gene. We cloned the uninterrupted gene and additional flanking sequences from K56-2 and conjugated this plasmid into strains J2315, C5424, and BC7. All the exconjugants recovered the ability to form LPS O antigen. We also determined that the structure of the strain K56-2 O antigen repeat, which was absent from the LPS of strain J2315, consisted of a trisaccharide unit made of rhamnose and two N-acetylgalactosamine residues. The complexity of the gene organization of the K56-2 O antigen cluster was also investigated by reverse transcription-PCR, revealing several transcriptional units, one of which also contains genes involved in lipid A-core oligosaccharide biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687196      PMCID: PMC545620          DOI: 10.1128/JB.187.4.1324-1333.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  59 in total

1.  Artemis: sequence visualization and annotation.

Authors:  K Rutherford; J Parkhill; J Crook; T Horsnell; P Rice; M A Rajandream; B Barrell
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Invasion of human type II pneumocytes by Burkholderia cepacia.

Authors:  P M Keig; E Ingham; K G Kerr
Journal:  Microb Pathog       Date:  2001-03       Impact factor: 3.738

4.  Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells.

Authors:  R M Baird; H Brown; A W Smith; M L Watson
Journal:  Immunopharmacology       Date:  1999-11

5.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

6.  Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation.

Authors:  L S Saini; S B Galsworthy; M A John; M A Valvano
Journal:  Microbiology       Date:  1999-12       Impact factor: 2.777

7.  In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production.

Authors:  M Lefebre; M Valvano
Journal:  Microbiology       Date:  2001-01       Impact factor: 2.777

8.  Burkholderia cepacia complex isolates survive intracellularly without replication within acidic vacuoles of Acanthamoeba polyphaga.

Authors:  Julie Lamothe; Sandra Thyssen; Miguel A Valvano
Journal:  Cell Microbiol       Date:  2004-12       Impact factor: 3.715

9.  Invasion and intracellular survival of Burkholderia cepacia.

Authors:  D W Martin; C D Mohr
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

10.  Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors:  S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

View more
  40 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  A Burkholderia cenocepacia MurJ (MviN) homolog is essential for cell wall peptidoglycan synthesis and bacterial viability.

Authors:  Yasmine Fathy Mohamed; Miguel A Valvano
Journal:  Glycobiology       Date:  2014-03-31       Impact factor: 4.313

3.  A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability.

Authors:  Ximena P Ortega; Silvia T Cardona; Alan R Brown; Slade A Loutet; Ronald S Flannagan; Dominic J Campopiano; John R W Govan; Miguel A Valvano
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

4.  Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo.

Authors:  Ronald S Flannagan; Daniel Aubert; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Membrane topology and identification of critical amino acid residues in the Wzx O-antigen translocase from Escherichia coli O157:H4.

Authors:  Cristina L Marolda; Bo Li; Michael Lung; Mei Yang; Anna Hanuszkiewicz; Amanda Roa Rosales; Miguel A Valvano
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

Review 6.  Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

Authors:  Elizabeth J Summer; Jason J Gill; Chris Upton; Carlos F Gonzalez; Ry Young
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

7.  Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia.

Authors:  Dalila Mil-Homens; Maria Inês Leça; Fábio Fernandes; Sandra N Pinto; Arsenio M Fialho
Journal:  J Bacteriol       Date:  2014-03-21       Impact factor: 3.490

8.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

9.  Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.

Authors:  P E Makidon; J Knowlton; J V Groom; L P Blanco; J J LiPuma; A U Bielinska; J R Baker
Journal:  Med Microbiol Immunol       Date:  2009-12-06       Impact factor: 3.402

10.  Identification of the flagellin glycosylation system in Burkholderia cenocepacia and the contribution of glycosylated flagellin to evasion of human innate immune responses.

Authors:  Anna Hanuszkiewicz; Paula Pittock; Fiachra Humphries; Hermann Moll; Amanda Roa Rosales; Antonio Molinaro; Paul N Moynagh; Gilles A Lajoie; Miguel A Valvano
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.